News

Reductions in prescribed benzodiazepines were especially noted in continuing prescriptions.

The cohort study is the first to report developmental cascades between disturbed sleep and depressive symptoms throughout childhood and early adolescence.

Research on the links between AMD and sleep dysfunction is limited but suggests a bidirectional relationship, a systematic review found.

Targeting a mean arterial blood pressure of 77 mm Hg or 63 mm Hg was not associated with significantly different percentages of patients dying or having severe disability or coma.

SGLT2 inhibitors reduce the risk of hospitalization for heart failure, extend survival, and improve overall health status, irrespective of ejection fraction, in patients with heart failure.

Presented at ESC Congress 22, results of the DELIVER trial indicate use of dapagliflozin (Farxiga) was associated with an 18% reduction in the primary outcome, with a 21% reduction in risk observed for worsening heart failure and a 12% reduction in risk observed for cardiovascular death compared with placebo therapy.

Clinical remission at week 4 and the steroid dose reduction rate at week 4 were linked to medication discontinuation within 12 weeks.

Treatment adherence remains a concern in psychiatry.

Severity of disease in patients with PAH coincided with cfDNA concentrations according to an NIH study with data from 2 independent cohorts.

The risk of coronary heart disease and stroke decreased by 22% for every 1 point rise in the sleep score at baseline.

Nonsegmental vitiligo not only affects the skin but can destroy melanocytes in other areas of the body including the eye, new research shows.

A recent study in Finland finds 2 major contributing factors to allergic disease in infants with familial risk.

Pfizer’s bivalent respiratory syncytial virus (RSV) prefusion F vaccine candidate demonstrated 85.7% efficacy in older patients with severe disease according to the phase 3 study.

Pegcetacoplan treatment effect accelerated between months 18-24 at reducing GA lesion growth in phase 3 DERBY and OAKS.

Hybrid visits were primarily for glaucoma (45.1%) and retinal issues (53.1%).

The treatment is the first pediatric indication of the treatment and the first treatment for younger patients with cGVHD.

Wearing glasses was inversely associated with COVID-19 in an unadjusted analysis, but the association did not remain when adjusting for confounders.

New research supports the inclusion of sleep disturbance in clinical evaluation and management in the treatment of Phelan-McDermid Syndrome (PMS) due to the drastic impact it can have on the quality of life for patients and their families.

Whole genome sequencing suggests both common and rare variants contribute to early onset drusen maculopathy.

Multivariate dimensional association scores resulted in an overall increase and normalization with age in the ADHD.

While investigators acknowledged the need for more high-quality, large-scale trials, cognitive behavioral therapy (CBT) serves as a promising intervention for insomnia in patients with cancer.

A recent study indicated no evident VTE risk in patients with eczema, despite FDA black box warnings for the drug class.

Regardless of frailty status, edoxaban 15 mg was associated with significantly reduced incidence of the study outcomes compared with placebo.

IBS-type symptoms were not linked to an increased likelihood of the need for glucocorticosteroids or flare, escalation, hospitalization, or intestinal resection.

Pharmacovigilance studies sifting through FDA adverse event reports confirm ocular side effects from PCSK9 inhibitors are infrequent and minor.

In this episode of Diabetes Dialogue, which was filmed just days after the conclusion of ADCES 22, our hosts take the time to dive deeper into the conference, their favorite sessions, and how the ADCES meetings have evolved to the changing role of diabetes care and education specialists over the years.

The investigational treatment SYNB1353 received FDA Fast Track Designation for homocystinuria (HCU), a rare metabolic disorder.

Vaccine-associated myocarditis was largely restricted to men younger than 40 years, according to the new findings.